Building Blocks
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,779 products)
- Chiral Building Blocks(1,238 products)
- Hydrocarbon Building Blocks(6,099 products)
- Organic Building Blocks(60,997 products)
Found 205208 products of "Building Blocks"
4-Amino-1-methylpyridin-2-one hydrochloride
CAS:Versatile small molecule scaffoldFormula:C6H8N2O·HClPurity:Min. 95%Molecular weight:160.6 g/molGSK 2830371-d4
CAS:GSK 2830371-d4 is a chemical compound that inhibits the growth of breast cancer cells. It has been shown to inhibit the proliferation of Her2+ breast cancer cells and induce apoptosis, which leads to long-term efficacy in inhibiting tumor growth. GSK 2830371-d4 also inhibits the activation of HER2+ breast cancer cells by suppressing the mitochondrial membrane potential, thereby inhibiting cell proliferation. This drug is also effective against carcinoma cell lines and shows no acute toxicities at low doses. GSK 2830371-d4 may be a potential biomarker for identifying patients with increased risk of developing breast cancer due to its ability to inhibit the activation of HER2+ breast cancer cells by suppressing the mitochondrial membrane potential.
Formula:C23H25D4ClN4O2SPurity:Min. 95%Molecular weight:465.04 g/molrac-(1R,2R)-2-(Piperazin-1-yl)cyclopentan-1-ol
CAS:Versatile small molecule scaffoldFormula:C9H18N2OPurity:Min. 95%Molecular weight:170.3 g/mol1,3-Diethylpiperazin-2-one
CAS:Versatile small molecule scaffoldFormula:C8H16N2OPurity:Min. 95%Molecular weight:156.23 g/mol2-{[(tert-Butoxy)carbonyl]amino}-2-(3-methoxycyclohexyl)acetic acid
CAS:Versatile small molecule scaffoldFormula:C14H25NO5Purity:Min. 95%Molecular weight:287.4 g/mol2-{[(tert-Butoxy)carbonyl]amino}-2-(2,4,6-trimethylphenyl)acetic acid
CAS:Versatile small molecule scaffoldFormula:C16H23NO4Purity:Min. 95%Molecular weight:293.36 g/mol2-{[(tert-butoxy)carbonyl]amino}-5-methylhexanoic acid
CAS:Versatile small molecule scaffoldFormula:C12H23NO4Purity:Min. 95%Molecular weight:245.3 g/mol2-{[(tert-Butoxy)carbonyl]amino}-4-(diethylamino)butanoic acid
CAS:Versatile small molecule scaffoldFormula:C13H26N2O4Purity:Min. 95%Molecular weight:274.36 g/mol3-{[(tert-Butoxy)carbonyl]amino}oxane-3-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C11H19NO5Purity:Min. 95%Molecular weight:245.3 g/mol2-{[(tert-Butoxy)carbonyl]amino}-5-methanesulfonylpentanoic acid
CAS:Versatile small molecule scaffoldFormula:C11H21NO6SPurity:Min. 95%Molecular weight:295.4 g/mol2-([(tert-Butoxy)carbonyl]amino)-3-(oxan-2-yl)propanoic acid
CAS:Versatile small molecule scaffoldFormula:C13H23NO5Purity:Min. 95%Molecular weight:273.33 g/mol2-{[(tert-Butoxy)carbonyl](methyl)amino}-2-(1-methyl-1H-pyrazol-4-yl)acetic acid
CAS:Versatile small molecule scaffoldFormula:C12H19N3O4Purity:Min. 95%Molecular weight:269.3 g/mol2-{[(tert-Butoxy)carbonyl]amino}-4-methylhexanoic acid
CAS:Versatile small molecule scaffoldFormula:C12H23NO4Purity:Min. 95%Molecular weight:245.32 g/mol3-(1,3-Benzoxazol-2-ylmethyl)piperazin-2-one
CAS:Versatile small molecule scaffoldFormula:C12H13N3O2Purity:Min. 95%Molecular weight:231.25 g/mol2-{[(tert-Butoxy)carbonyl](methyl)amino}-4,4-dimethylpentanoic acid
CAS:Versatile small molecule scaffoldFormula:C13H25NO4Purity:Min. 95%Molecular weight:259.34 g/mol2-{[(tert-Butoxy)carbonyl](methyl)amino}-2-(oxan-4-yl)acetic acid
CAS:Versatile small molecule scaffoldFormula:C13H23NO5Purity:Min. 95%Molecular weight:273.3 g/mol2-{[(tert-Butoxy)carbonyl]amino}-3-(oxolan-3-yl)propanoic acid
CAS:Versatile small molecule scaffold
Formula:C12H21NO5Purity:Min. 95%Molecular weight:259.3 g/mol3-Amino-1-[(2,4-dimethoxyphenyl)methyl]pyrrolidin-2-one
CAS:Versatile small molecule scaffold
Formula:C13H18N2O3Purity:Min. 95%Molecular weight:250.29 g/mol2-{[(tert-Butoxy)carbonyl](methyl)amino}-2-(2,3-dichlorophenyl)acetic acid
CAS:Versatile small molecule scaffoldFormula:C14H17Cl2NO4Purity:Min. 95%Molecular weight:334.2 g/mol2-([(tert-Butoxy)carbonyl]amino)-3-(oxolan-2-yl)propanoic acid
CAS:Versatile small molecule scaffoldFormula:C12H21NO5Purity:Min. 95%Molecular weight:259.3 g/mol2-{[(tert-Butoxy)carbonyl]amino}-4-(dimethylamino)butanoic acid
CAS:Versatile small molecule scaffoldFormula:C11H22N2O4Purity:Min. 95%Molecular weight:246.3 g/mol2-{[(tert-Butoxy)carbonyl]amino}-2-(4-ethoxyphenyl)acetic acid
CAS:Versatile small molecule scaffoldFormula:C15H21NO5Purity:Min. 95%Molecular weight:295.33 g/mol2-{[(tert-Butoxy)carbonyl]amino}-3-(pyrimidin-2-yl)propanoic acid
CAS:Versatile small molecule scaffoldFormula:C12H17N3O4Purity:Min. 95%Molecular weight:267.28 g/mol2-{[(tert-Butoxy)carbonyl]amino}-4-(pyridin-2-yl)butanoic acid
CAS:Versatile small molecule scaffold
Formula:C14H20N2O4Purity:Min. 95%Molecular weight:280.32 g/mol3-Amino-1-{[3-(trifluoromethyl)phenyl]methyl}piperidin-2-one
CAS:Versatile small molecule scaffoldFormula:C13H15F3N2OPurity:Min. 95%Molecular weight:272.27 g/mol3-Amino-1-[1-(2-fluorophenyl)ethyl]piperidin-2-one
CAS:Versatile small molecule scaffoldFormula:C13H17FN2OPurity:Min. 95%Molecular weight:236.28 g/mol3-Amino-1-[1-(4-fluorophenyl)ethyl]piperidin-2-one
CAS:Versatile small molecule scaffoldFormula:C13H17FN2OPurity:Min. 95%Molecular weight:236.28 g/molBenzyl 2,4-dioxo-1,8-diazaspiro[4.5]decane-8-carboxylate
CAS:Versatile small molecule scaffoldFormula:C16H18N2O4Purity:Min. 95%Molecular weight:302.32 g/mol2-Fluoro-3-propoxypyrazine
CAS:Versatile small molecule scaffoldFormula:C7H9FN2OPurity:Min. 95%Molecular weight:156.16 g/moltert-Butyl 3-(3-methyl-2-oxobutyl)azetidine-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C13H23NO3Purity:Min. 95%Molecular weight:241.33 g/molN-Methyl-N-(prop-2-yn-1-yl)methanesulfonoimidamide
CAS:Versatile small molecule scaffoldFormula:C5H10N2OSPurity:Min. 95%Molecular weight:146.21 g/molMethyl 3-(2-((tert-butoxycarbonyl)amino)ethyl)benzoate
CAS:Versatile small molecule scaffold
Formula:C15H21NO4Purity:Min. 95%Molecular weight:279.33 g/molN-tert-Butylpiperidine-2-carboxamide
CAS:N-tert-Butylpiperidine-2-carboxamide is a small molecule that has been shown to bind to the cavity of the active site of human thiopurine S-methyltransferase (TPMT), blocking access by substrates and competitive inhibitors. It was synthesized as a peptidomimetic inhibitor for TPMT, which is an enzyme that catalyzes the methylation of thiopurines, such as 6-MP. The X-ray crystallographic studies revealed that N-tert-butylpiperidine-2-carboxamide is a homodimeric molecule with two binding sites on each monomer. The inhibition of TPMT by N-tert-butylpiperidine-2-carboxamide results in increased levels of 6MP and decreased levels of 6TG, leading to improved therapeutic outcomes when given with 6MP.Formula:C10H20N2OPurity:Min. 95%Molecular weight:184.28 g/mol4-[(Thiophen-3-yl)methyl]phenol
CAS:Versatile small molecule scaffold
Formula:C11H10OSPurity:Min. 95%Molecular weight:190.26 g/molMethyl 4-hydroxypiperidine-4-carboxylate hydrochloride
CAS:Versatile small molecule scaffoldFormula:C7H14ClNO3Purity:Min. 95%Molecular weight:195.64 g/mol2-(4-Benzylphenoxy)ethan-1-amine hydrochloride
CAS:Versatile small molecule scaffoldFormula:C15H18ClNOPurity:Min. 95%Molecular weight:263.76 g/mol2-(1-Benzyl-1H-imidazol-5-yl)acetic acid hydrochloride
CAS:Versatile small molecule scaffoldFormula:C12H13ClN2O2Purity:Min. 95%Molecular weight:252.69 g/mol3-(1-Hydroxybutan-2-yl)-2-sulfanyl-3,4-dihydroquinazolin-4-one
CAS:Versatile small molecule scaffoldFormula:C12H14N2O2SPurity:Min. 95%Molecular weight:250.32 g/mol4H,5H-Imidazo[1,5-a]quinoxalin-4-one
CAS:4H,5H-Imidazo[1,5-a]quinoxalin-4-one is a potent inhibitor of phosphodiesterase. It has been shown to bind to the active site of the enzyme and inhibit phosphodiesterase activity in vitro. The drug inhibits phosphodiesterase type 5 (PDE5) which is an enzyme that breaks down cyclic guanosine monophosphate (cGMP). This inhibition leads to increased levels of cGMP and can lead to dysfunction in some tissues.Formula:C10H7N3OPurity:Min. 95%Molecular weight:185.18 g/mol4-(1-Methyl-1H-pyrazol-3-yl)benzaldehyde
CAS:Versatile small molecule scaffoldFormula:C11H10N2OPurity:Min. 95%Molecular weight:186.21 g/mol4-(1-Methyl-1H-pyrazol-4-yl)benzaldehyde
CAS:Versatile small molecule scaffoldFormula:C11H10N2OPurity:Min. 95%Molecular weight:186.21 g/mol3-(1-Methyl-1H-pyrazol-4-yl)benzaldehyde
CAS:Versatile small molecule scaffoldFormula:C11H10N2OPurity:Min. 95%Molecular weight:186.21 g/mol(4-(1H-Pyrazol-3-yl)phenyl)methanol
CAS:Versatile small molecule scaffoldFormula:C10H10N2OPurity:Min. 95%Molecular weight:174.2 g/mol(5-Phenyl-1H-pyrazol-3-yl)methanol
CAS:Versatile small molecule scaffoldFormula:C10H10N2OPurity:Min. 95%Molecular weight:174.2 g/mol5-[3-(Hydroxymethyl)phenyl]-2H-tetrazole
CAS:Versatile small molecule scaffoldFormula:C8H8N4OPurity:Min. 95%Molecular weight:176.18 g/mol4-(1,3-Oxazol-5-yl)benzaldehyde
CAS:Versatile small molecule scaffoldFormula:C10H7NO2Purity:Min. 95%Molecular weight:173.17 g/mol4-(1H-Pyrazol-1-ylmethyl)benzonitrile
CAS:4-((1H-Pyrazol-1-yl)methyl)benzonitrile is a chemical compound that is used as an antidepressant in psychiatric patients. It has been shown to have a positive effect on the mood of patients with major depressive disorder and bipolar disorder, but does not have significant effects on the overall sleep patterns. The drug has also been shown to be effective against cancer, specifically colorectal cancer. This medication has a low energy profile and no serious adverse effects on the cardiovascular system.Formula:C11H9N3Purity:Min. 95%Molecular weight:183.21 g/mol2-(Oxan-4-yl)propan-2-ol
CAS:Versatile small molecule scaffoldFormula:C8H16O2Purity:Min. 95%Molecular weight:144.21 g/mol3-Methoxybenzylhydrazine dihydrochloride
CAS:Versatile small molecule scaffoldFormula:C8H14Cl2N2OPurity:Min. 95%Molecular weight:225.12 g/mol(7-Chloro-1,3-benzodioxol-5-yl)methanol
CAS:Controlled ProductVersatile small molecule scaffold
Formula:C8H7ClO3Purity:Min. 95%Molecular weight:186.59 g/mol
